To include your compound in the COVID-19 Resource Center, submit it here.

RG-101 regulatory update

Regulus said FDA issued a request for information related to the clinical hold on RG-101. The agency requested a detailed safety

Read the full 215 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE